loading
Schlusskurs vom Vortag:
$17.59
Offen:
$17.59
24-Stunden-Volumen:
160.47K
Relative Volume:
0.48
Marktkapitalisierung:
$577.59M
Einnahmen:
$4.12M
Nettoeinkommen (Verlust:
$-56.68M
KGV:
-3.2402
EPS:
-5.5429
Netto-Cashflow:
$-51.44M
1W Leistung:
+1.58%
1M Leistung:
-17.24%
6M Leistung:
-27.23%
1J Leistung:
-17.39%
1-Tages-Spanne:
Value
$17.50
$18.19
1-Wochen-Bereich:
Value
$16.91
$18.45
52-Wochen-Spanne:
Value
$13.37
$32.27

Dianthus Therapeutics Inc Stock (DNTH) Company Profile

Name
Firmenname
Dianthus Therapeutics Inc
Name
Telefon
929-999-4055
Name
Adresse
7 TIMES SQUARE, NEW YORK
Name
Mitarbeiter
78
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
DNTH's Discussions on Twitter

Vergleichen Sie DNTH mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
DNTH
Dianthus Therapeutics Inc
17.96 568.59M 4.12M -56.68M -51.44M -5.5429
Biotechnology icon
ONC
Beone Medicines Ltd Adr
258.27 26.01B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.85 114.30B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.3499 41.83M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
83.98 6.29B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
484.93 63.90B 14.09B 4.50B 2.96B 39.28

Dianthus Therapeutics Inc Stock (DNTH) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-12-20 Eingeleitet TD Cowen Buy
2024-10-03 Eingeleitet Oppenheimer Outperform
2024-07-26 Eingeleitet Robert W. Baird Outperform
2024-06-27 Eingeleitet Cantor Fitzgerald Overweight
2024-05-16 Eingeleitet H.C. Wainwright Buy
2024-02-15 Eingeleitet Stifel Buy
2023-12-26 Eingeleitet Jefferies Buy
2023-11-22 Eingeleitet Wedbush Outperform
2023-10-30 Eingeleitet Guggenheim Buy
2023-09-28 Eingeleitet Raymond James Outperform
2022-08-25 Herabstufung Goldman Buy → Neutral
2022-01-06 Hochstufung Goldman Neutral → Buy
2021-08-20 Fortgesetzt Goldman Neutral
2021-08-03 Herabstufung JP Morgan Overweight → Neutral
2021-07-22 Bestätigt B. Riley Securities Buy
2021-06-29 Eingeleitet Cantor Fitzgerald Overweight
2021-06-15 Eingeleitet BTIG Research Buy
2021-05-18 Eingeleitet B. Riley Securities Buy
2021-01-07 Eingeleitet Mizuho Buy
2020-06-08 Hochstufung Goldman Neutral → Buy
2019-03-25 Herabstufung Goldman Buy → Neutral
2019-03-15 Eingeleitet Raymond James Outperform
Alle ansehen

Dianthus Therapeutics Inc Aktie (DNTH) Neueste Nachrichten

pulisher
Jun 03, 2025

Millennium Management LLC Has $1.97 Million Stake in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat

Jun 03, 2025
pulisher
Jun 03, 2025

Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Shares Acquired by Millennium Management LLC - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

BNP Paribas Financial Markets Makes New Investment in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World

Jun 03, 2025
pulisher
Jun 01, 2025

Dianthus Therapeutics (NASDAQ:DNTH) Shares Down 5.2%Time to Sell? - MarketBeat

Jun 01, 2025
pulisher
May 31, 2025

Analysts Set Dianthus Therapeutics, Inc. (NASDAQ:DNTH) PT at $53.00 - MarketBeat

May 31, 2025
pulisher
May 30, 2025

Deutsche Bank AG Increases Holdings in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World

May 30, 2025
pulisher
May 29, 2025

Dianthus Therapeutics to Webcast Presentation at the Jefferies Global Healthcare Conference - The Manila Times

May 29, 2025
pulisher
May 29, 2025

Autoimmune Disease Biotech Dianthus Therapeutics CEO Takes Stage at Major Jefferies Conference - Stock Titan

May 29, 2025
pulisher
May 26, 2025

Northern Trust Corp Acquires 42,923 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat

May 26, 2025
pulisher
May 26, 2025

Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Shares Purchased by Woodline Partners LP - MarketBeat

May 26, 2025
pulisher
May 26, 2025

Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Receives Average Recommendation of “Buy” from Brokerages - Defense World

May 26, 2025
pulisher
May 25, 2025

Point72 Asset Management L.P. Reduces Stock Holdings in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat

May 25, 2025
pulisher
May 24, 2025

Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Shares Acquired by Vestal Point Capital LP - MarketBeat

May 24, 2025
pulisher
May 23, 2025

Dianthus Therapeutics appoints new board member By Investing.com - Investing.com India

May 23, 2025
pulisher
May 23, 2025

Dianthus Therapeutics Appoints Simon Read, Ph.D., to Board of Directors - citybiz

May 23, 2025
pulisher
May 22, 2025

Dianthus Therapeutics appoints new board member - Investing.com Australia

May 22, 2025
pulisher
May 22, 2025

Dianthus Therapeutics Announces Board Changes and Elections - TipRanks

May 22, 2025
pulisher
May 22, 2025

Former Novartis-Acquired CEO Joins Dianthus Board Ahead of Critical Phase 2 Data - Stock Titan

May 22, 2025
pulisher
May 21, 2025

Janus Henderson Group PLC Buys 136,314 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat

May 21, 2025
pulisher
May 20, 2025

Buy Rating Affirmed for Dianthus Therapeutics: Promising Clinical Potential of DNTH103 in CIDP Treatment - TipRanks

May 20, 2025
pulisher
May 19, 2025

Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Position Raised by Octagon Capital Advisors LP - MarketBeat

May 19, 2025
pulisher
May 18, 2025

Robert W. Baird Has Lowered Expectations for Dianthus Therapeutics (NASDAQ:DNTH) Stock Price - MarketBeat

May 18, 2025
pulisher
May 18, 2025

FY2025 EPS Estimates for DNTH Lowered by Cantor Fitzgerald - Defense World

May 18, 2025
pulisher
May 18, 2025

Dianthus Therapeutics (NASDAQ:DNTH) Earns "Buy" Rating from HC Wainwright - MarketBeat

May 18, 2025
pulisher
May 17, 2025

Dianthus Therapeutics (NASDAQ:DNTH) Announces Quarterly Earnings Results, Beats Estimates By $0.04 EPS - MarketBeat

May 17, 2025
pulisher
May 17, 2025

Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Shares Bought by Price T Rowe Associates Inc. MD - Defense World

May 17, 2025
pulisher
May 16, 2025

Wedbush Research Analysts Raise Earnings Estimates for DNTH - Defense World

May 16, 2025
pulisher
May 16, 2025

HC Wainwright Issues Positive Forecast for DNTH Earnings - Defense World

May 16, 2025
pulisher
May 16, 2025

Tower Research Capital LLC TRC Sells 944 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World

May 16, 2025
pulisher
May 15, 2025

Robert W. Baird Issues Pessimistic Forecast for Dianthus Therapeutics (NASDAQ:DNTH) Stock Price - Defense World

May 15, 2025
pulisher
May 15, 2025

HC Wainwright Reaffirms Buy Rating for Dianthus Therapeutics (NASDAQ:DNTH) - Defense World

May 15, 2025
pulisher
May 14, 2025

Dianthus Therapeutics (NASDAQ:DNTH) Trading Down 6.1% Following Analyst Downgrade - Defense World

May 14, 2025
pulisher
May 13, 2025

DNTH: HC Wainwright & Co. Reiterates Buy Rating with $40 Target - GuruFocus

May 13, 2025
pulisher
May 13, 2025

DNTH Stock Target Price Lowered by Analyst Baird | DNTH Stock Ne - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Breaking Down Dianthus Therapeutics: 5 Analysts Share Their Views - Benzinga

May 13, 2025
pulisher
May 13, 2025

Wedbush Adjusts Price Target on Dianthus Therapeutics to $34 From $36, Maintains Outperform Rating - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Dianthus (DNTH) Target Price Adjusted Amid Q1 Pipeline Update | - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 Financial Results - The Manila Times

May 13, 2025
pulisher
May 13, 2025

Dianthus Therapeutics Reports Increased R&D Expenses - TipRanks

May 13, 2025
pulisher
May 12, 2025

Dianthus Therapeutics, Inc. (DNTH) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 12, 2025
pulisher
May 11, 2025

Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Position Lifted by Braidwell LP - MarketBeat

May 11, 2025
pulisher
May 10, 2025

Avidity Partners Management LP Lowers Holdings in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat

May 10, 2025

Finanzdaten der Dianthus Therapeutics Inc-Aktie (DNTH)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$1.16
price up icon 0.00%
$573.50
price down icon 0.54%
$36.08
price up icon 15.90%
$305.31
price up icon 0.51%
$4.75
price up icon 3.70%
$484.93
price down icon 0.60%
Kapitalisierung:     |  Volumen (24h):